cally significant differences in any of the above conventional variables. The average glucose infusion rate (an index for insulin resistance) of 2.68 ± 1.86 mg × kg 1 × min 1 for the coronary artery disease group was, however, lower than 4.55 ± 2.2 mg × kg 1 × min 1 for the non-macrovascular disease group (p = 0.004 by Mann-Whitney test) (Fig. 1) . One patient with a normal glucose infusion rate (7.28 mg × kg 1 × min 1 ) developed unstable angina. This patient smoked and had hypertension and incipient nephropathy but obesity, hyperinsulinaemia, and dyslipidaemia were not observed. Risk ratio analysis by quartile showed that patients whose glucose infusion rate fell in the lowest quartile had a relative risk of developing cardiovascular disease approximately seven times higher than patients with higher infusion rates. This result was the same whether the comparison was to an individual higher quartile or the combined quartiles above the lowest. We did not measure the serum insulin concentration in all cases because about one third of the subjects used variable doses of daily insulin. The clinical features common to ten coronary artery disease patients were that they were nonobese and had a higher prevalence of nephropathy, although they were not statistically significantly different from those for the non-macrovascular disease group. Based on these results we concluded that insulin resistance either alone or in combination with some undetermined risk factors, contributes to the development of coronary artery disease in Japanese Type II diabetic subjects. Type II diabetic subjects showing lower insulin sensitivity should therefore be considered as a high-risk group for coronary artery disease and their coronary management should be closely monitored. Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus
Dear Sir, The Pima Indians of Arizona have the world's highest incidence and prevalence of Type II (non-insulin-dependent) diabetes mellitus and the disease is now common in Pima Indian children [1] . Based on clinical characteristics and lack of islet cell antibodies in a previous sample of 46 diabetic Pimas aged 17±47 years, their disease was described as being exclusively Type II (i. e. not immune mediated and not insulin-dependent) diabetes [2] . There is no evidence for linkage to known MODY loci in the Pimas [3] . To characterize diabetes further in Pima children, we determined the presence of glutamic acid decarboxylase antibodies (GAD65Ab) which are positive in 75±80 % of patients with the autoimmune form of Type I (insulin-dependent) diabetes mellitus [4] and rarely found in children without diabetes [5] . This report includes the 125 diabetic Pima subjects aged 5 to 19 years, reported in our recent paper [1] . Diabetes was diagnosed by the World Health Organisation WHO criteria and obesity was estimated according to relative weight. Sera frozen at the time of each subject's first examination with diabetes (the date of diagnosis for 78 % of the subjects) were used for the antibody test. We measured GAD65Ab in a radiobinding immunoassay on coded serum samples [5] . The levels were expressed as relative index (GAD65 index); the assay considers a positive at 0.07, the 97.5 centile based on 200 normal controls (unpublished data).
The characteristics of the 125 children with diabetes, at the first examination at or after the time of diagnosis, are shown in the Table 1 . Their clinical features indicate Type II diabetes and include a family history of Type II diabetes in 92 % of the subjects, obesity (relative weight in the upper tertile, ³ 110 %) in 68 %, lack of symptoms at diagnosis (78 % were diagnosed at a research examination, following a 75-g oral glucose tolerance test, OGTT) and infrequent subsequent insulin treatment (17 %). The levels of GAD65Ab, expressed as GAD65 indices, were similar in Pima Indian children with diabetes (median = 0.027; range = ±0.06, 0.14), and in 85 non-diabetic Swedish children (median = ±0.007; range = ±0.03, 0.82). By contrast, they were substantially lower than in 155 Swedish children with newly diagnosed Type I diabetes (median = 0.29; range = ±0.02, 2.4) [5] .
Of the 125 Pima children with diabetes only seven (5.6 %) had GAD indices of 0.07 or more. The expected rate of indices ³ 0.07 was 2.5 %; therefore, the excess over a non-diabetic cohort was only 3.1 %. The weakly GAD65Ab positive children were of full Indian heritage, obese and had at least one parent with Type II diabetes. One was subsequently treated with insulin. This subject was born to a mother with Type II diabetes. At age 3.5 years he had an OGTT diagnostic of diabetes (2-h glucose 12.2 mmol/l), but several normal tests during subsequent years. At age 11 years he had a GAD65Ab index of 0.09 and a 2-h glucose concentration of 10.8 mmol/l. At age 13 years he developed symptoms of diabetes (polyuria and enuresis) and had On the other hand, we previously documented that the novel 8296 mitochondrial tRNA Lys mutation (DM-Mt 8296) [2, 3] was associated with diabetes and screened 1216 diabetic subjects as well as 44 patients with sensorineural deafness, and 12 subjects were enrolled in our study [2, 3] . In these studies we evaluated neuroimaging findings in patients with DM-Mt 8296, using magnetic resonance imaging and Xenon computed tomography cerebral blood flow. Ten of our previous subjects underwent magnetic resonance imaging and five of these also underwent Xenon CT cerebral blood flow imaging of the brain after giving informed consent to participate in this study. Magnetic resonance imaging and angiography were done using a 1.5 T Simazu superconducting system. Xenon computed tomography was done using a stable isotope of xenon in conjunction with computed tomography to improve detection of local blood flow [4] . The patients breathed a mixture of oxygen and 30 % xenon. Three min for wash-in and 5 min for wash-out were necessary to complete the examination. The degree of change in regional image density (x-ray absorption), combined with the arterial wash-in and wash-out curves, were used to derive local blood flow values. The clinical profiles of the 10 subjects are summarized in Table 1 . Their age ranged from 46 to 75 years (means ± SD, Letters to the editor 1266
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